9 results
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
30d mortality #Diagnosis ... #Management #EM ... #IM #PCC #PESI ... #sPESI #risk #score ... #PE #PulmonaryEmbolism
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
PulmonaryEmbolism #Diagnosis ... #EM #IM #PCC #PESI ... #sPESI #risk #score ... #PE #Table
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
Mortality #EBM #Diagnosis ... #EM #IM #PCC #PESI ... #sPESI #risk #score ... #PE #Sensitivity
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
and Management ... Algorithm STEMI: ... pleuritic CP, Dyspnea, PE ... swelling, Wells score ... #Management #Algorithm
Listeriosis Summary - Listeria Monocytogenes
Pathogen: Listeria Monocytogenes - Gram-positive rod, Aerobic, facultative anaerobe, motile, beta-hemolytic, Non-spore-forming
Risk
beta-hemolytic, Non-spore-forming ... Risk Factors: ... Gastroenteritis) • PCR ... / CT if focal symptoms ... #management #infectiousdiseases
Listeriosis Summary - Listeria Monocytogenes
Pathogen: Listeria Monocytogenes - Gram-positive rod, Aerobic, facultative anaerobe, motile, beta-hemolytic, Non-spore-forming
Risk
beta-hemolytic, Non-spore-forming ... Risk Factors: ... Gastroenteritis) • PCR ... / CT if focal symptoms ... #management #infectiousdiseases
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Attempt if high risk ... : >3 symptoms, or ... Infection (sepsis), PE ... fluid overload, PCC ... #management #hematology
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
• URI sx (HA, sore ... incr in 27-75% • PCT ... 7-28% -> Incr risk ... Evaluation #Guide #Diagnosis ... #Algorithm #Protocol
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/PE ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... #management #hematology